RecruitingNot ApplicableNCT05562232
The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms
The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms - a Pilot Study Protocol
Sponsor
Psychiatric Research Unit, Region Zealand, Denmark
Enrollment
45 participants
Start Date
Aug 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.
Eligibility
Min Age: 20 YearsMax Age: 45 Years
Inclusion Criteria2
- Have had PPCS for a minimum of six months and a maximum of 18 months at the start of the study.
- Being between 20 and 45 years of age
Exclusion Criteria6
- Elite athletes, as well as people who in general is physical active, at an intensity of moderat to high, for more than ten hours a week on average.
- Participation in other interventions/treatment that could affect this study
- Have had PPCS in:
- =<6 months
- =>18 months
- Pregnant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTCreatine Monohydrate
Follows
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05562232
Related Trials
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
NCT056630345 locations
Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain Injury
NCT074367543 locations
Facilitating Access to Specialty Treatment
NCT057414111 location
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
NCT0486731717 locations
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
NCT070445961 location